Khortnal Delvecchio

Khortnal Delvecchio practices at HCA Florida Largo Hospital in Largo, Florida, part of HCA Healthcare.

Khortnal Delvecchio's NPI, 1578989224, was assigned on March 5, 2014. Khortnal Delvecchio graduated from Michigan State University College Of Osteopathic Medicine in 2014. Khortnal Delvecchio holds Florida license OS18070.

Khortnal Delvecchio's primary practice is HCA Florida Largo Hospital, at 201 14th St SW, Largo, FL 33770 in Pinellas County. The practice phone is (727) 588-5200.

Khortnal Delvecchio's primary practice is HCA Florida Largo Hospital in Largo, Florida, part of HCA Healthcare. The medical group on file is Northpointe Physicians Group. Dmand AI also links Khortnal Delvecchio to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Khortnal Delvecchio practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Khortnal Delvecchio's primary specialty in the NPI Registry, under taxonomy code 208600000X. Khortnal Delvecchio is board certified in surgery by the AOA Board of Surgery. Khortnal Delvecchio is licensed in Florida.

Dmand AI lists kidney transplant among the conditions Khortnal Delvecchio treats.

CMS data shows 93 Medicare services from Khortnal Delvecchio across 2 procedure codes in 2024, for 65 Medicare patients. Medicare paid $10,661 for them.

CMS counts 65 Medicare patients who saw Khortnal Delvecchio in 2024. The largest group is 65 to 74, with 35 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 28% are also on Medicaid. Their average risk score is 7.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Khortnal Delvecchio's median patient age at 62, with 35% women.

In 2024, Khortnal Delvecchio wrote 240 Medicare Part D claims for 27 patients. 91% of them were for generic drugs. CMS names the drug for 107 of them, across 5 drugs with 11 or more claims each, at $5,030 in total drug cost. In 2023, CMS named 173 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Khortnal Delvecchio for performance year 2024, reported as part of a group. Khortnal Delvecchio accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Khortnal Delvecchio, published from 2010 to 2021. The most frequent topics are Phosphatidylinositol 3-Kinases. Khortnal Delvecchio's most frequent co-authors are Abbas Al-Kurd, MD, Kelly Michelle Collins, MD and Shunji Nagai, MD.

CMS Open Payments shows 5 general payments to Khortnal Delvecchio from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $125.

Khortnal Delvecchio graduated from Michigan State University College Of Osteopathic Medicine in 2014.

Khortnal Delvecchio is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.